Drug companies should drop their patents and collaborate to fight coronavirus
Enrico Bonadio, reader in Intellectual Property Law, City, University of London, and Andrea Baldini, associate Professor of Aesthetics and Art Theory, Nanjing University, explain why pharmaceutical companies need to collaborate to combat coronavirus.
